UNII 451W47IQ8X

SODIUM CHLORIDE

Unique Ingredient Identifier 451W47IQ8X is listed as a ingredient substance
Unii451W47IQ8X
Preferred Substance NameSODIUM CHLORIDE
Rn7647-14-5
Ec231-598-3
NcitC29974
Rxcui9863
Pubchem5234
Inn Id4155
Molecular FormulaCl.Na
InchikeyFAPWRFPIFSIZLT-UHFFFAOYSA-M
Smiles[Na+].[Cl-]
Unii TypeINGREDIENT SUBSTANCE
RN7647-14-5
EC231-598-3
NCITC29974
RXCUI9863
INN ID4155
MFCl.Na
INCHI KEYFAPWRFPIFSIZLT-UHFFFAOYSA-M
SMILES[Na+].[Cl-]

Alternate Names

Dosage Forms

UNII 451W47IQ8X SODIUM CHLORIDE is commonly included in medications in the following forms.

RouteDosage FormPotency
IV(INFUSION)INJECTION0.59 %
OPHTHALMICSOLUTION0.81 %
INTRAVENOUSINJECTION0.9 %
INTRAVENOUSSOLUTION0.9 %
AN,CNBLK INTRATHECALINJECTION0.8 %
AN,INFILTRATIONINJECTABLE NA
AN,INFILTRATIONINJECTION0.9 %
AN,INFILTRATIONSOLUTION, INJECTION0.65 %
AN,SYMPATHETIC NBLKINJECTION0.3 %
AURICULAR (OTIC)SOLUTION9 %
AURICULAR (OTIC)SUSPENSION0.86 %
AURICULAR (OTIC)SUSPENSION, LIQUID0.9 %
CAUDAL BLOCKINJECTABLE NA
CAUDAL BLOCKINJECTION0.9 %
DENTALINJECTABLE0.3 %
DENTALINJECTION0.6 %
EPIDURALINJECTION24 %
EPIDURALINJECTION8.6 mg/1mL
EPIDURALINJECTION, SOLUTION8 mg/1mL
EPIDURALLIQUID, WATER, STERILE, FOR INJECTION0.8 %
EPIDURALSOLUTION0.9 %
EPIDURALSOLUTION, INJECTION0.9 %
EPIDURAL, INFILTRATION, NERVE BLOCKINJECTION8.6 MG/ML
EXTRACORPOREALINJECTION0.9 %
EXTRACORPOREALSOLUTION0.8 %
IM - IVINJECTABLE0.9 %
IM - IVINJECTION14 %
IM - IVINJECTION4.9 mg/mL
IM - IVLIQUID, WATER, STERILE, FOR INJECTION0.8 %
IM - IVPOWDER, FOR INJECTION SOLUTION9 %
IM - IVPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED18 %
IM - IVSOLUTION0.9 %
IM - IVSOLUTION, INJECTION0.9 %
IM - IV - SCINJECTION0.9 %
IM - IV - SCSOLUTION, INJECTION NA
IM - SCINJECTION0.9 %
INFILTRATIONINJECTION8.6 mg/1mL
INFILTRATIONINJECTION0.86 %
INFILTRATIONINJECTION, LIPOSOMAL0.54 %
INFILTRATIONINJECTION, SOLUTION7 MG/1ML
INFILTRATIONSOLUTION, INJECTION0.85 %
INHALATIONINHALANT NA
INHALATIONINHALANT SOLUTION DOSAGE FORM11.25 mg/5mL
INHALATIONSOLUTION27 mg/3 mL
INHALATIONSOLUTION9 mg/3mL
INHALATIONSOLUTION8 MG/1ML
INHALATIONSOLUTION0.9 %W/V
INHALATIONSOLUTION, FOR INHALATION1.13 %
INHALATIONSUSPENSION17.2 mg/2mL
INHALATIONSUSPENSION, FOR INHALATION0.85 %
INJECTIONINJECTION8.5 mg/1mL
INJECTIONINJECTION, SOLUTION7 mg/1mL
INTRA-ARTERIALINJECTABLE0.49 %
INTRA-ARTERIALINJECTION19.6 %
INTRA-ARTERIALINJECTION4.9 mg/mL
INTRA-ARTERIALPOWDER, FOR INJECTION SOLUTION0.14 %
INTRA-ARTERIALSOLUTION0.9 %
INTRA-ARTERIALSOLUTION, INJECTION0.05 %
INTRA-ARTERIALSUSPENSION, INJECTION1.5 mg/1mL
INTRA-ARTICULARINJECTABLE0.67 %
INTRA-ARTICULARINJECTION6.5 MG/1ML
INTRA-ARTICULARINJECTION0.9 %
INTRA-ARTICULARINJECTION, SUSPENSION, EXTENDED RELEASE45 MG
INTRA-ARTICULARINJECTION, SUSTAINED ACTION NA
INTRA-ARTICULARSUSPENSION0.48 %
INTRABURSALINJECTION0.9 %
INTRACARDIACINJECTION35 mg/5mL
INTRACARDIACINJECTION0.7 %
INTRACARDIACSOLUTION, INJECTION NA
INTRACAUDALINJECTION0.86 %
INTRACAUDALINJECTION, SOLUTION7 MG/1ML
INTRACAVITARYINJECTION0.82 %
INTRACAVITARYPOWDER, FOR INJECTION SOLUTION NA
INTRADERMALINJECTION0.7 %
INTRADERMALINJECTION, SUSTAINED ACTION NA
INTRALESIONALINJECTABLE0.87 %
INTRALESIONALINJECTION0.85 %
INTRALESIONALINJECTION, SUSTAINED ACTION0.9 %
INTRALESIONALSUSPENSION, INJECTION1.5 mg/1mL
INTRALESIONALSUSPENSION, INJECTION0.22 %
INTRAMUSCULARINJECTABLE3.3 mg/1mL
INTRAMUSCULARINJECTABLE0.87 %W/V
INTRAMUSCULARINJECTION9 MG/1ML
INTRAMUSCULARINJECTION0.86 %W/V
INTRAMUSCULARINJECTION, SOLUTION4.6 MG/1ML
INTRAMUSCULARINJECTION, SOLUTION0.9 %W/V
INTRAMUSCULARINJECTION, SOLUTION0.8 %
INTRAMUSCULARINJECTION, SUSPENSION0.87 %
INTRAMUSCULARINJECTION, SUSPENSION, EXTENDED RELEASE1.96 %
INTRAMUSCULARINJECTION, SUSTAINED ACTION0.9 %W/V
INTRAMUSCULARLIQUID0.67 %W/V
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION22.6 %
INTRAMUSCULARPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH 0.24 %
INTRAMUSCULARSOLUTION9 mg/1mL
INTRAMUSCULARSOLUTION, INJECTION0.9 %W/V
INTRAMUSCULARSUSPENSION0.9 %
INTRAMUSCULARSUSPENSION, INJECTION8.68 MG/1ML
INTRAMUSCULARSUSPENSION, INJECTION0.87 %W/V
INTRAOCULARSOLUTION9 mg/1mL
INTRAOCULARSOLUTION0.7 %
INTRAPERITONEALPOWDER, FOR INJECTION SOLUTION22.6 %
INTRAPERITONEALSOLUTION0.54 %
INTRAPLEURALPOWDER, FOR INJECTION SOLUTION22.6 %
INTRASYNOVIALINJECTABLE0.87 %
INTRASYNOVIALINJECTION0.9 %
INTRASYNOVIALINJECTION, SUSTAINED ACTION0.9 %
INTRASYNOVIALSUSPENSION, INJECTION0.22 %
INTRA-SYNOVIALSUSPENSION, INJECTION1.5 mg/1mL
INTRATHECALINJECTABLE0.9 %
INTRATHECALINJECTION19.6 %
INTRATHECALINJECTION9 MG/ML
INTRATHECALINJECTION, SOLUTION8 mg/1mL
INTRATHECALINJECTION, SUSPENSION, LIPOSOMAL9 %
INTRATHECALPOWDER, FOR INJECTION SOLUTION0.14 %
INTRATHECALSOLUTION, INJECTION7.2 MG/1ML
INTRATHECALSOLUTION, INJECTION0.9 %
INTRATRACHEALINJECTION1.2 %
INTRATRACHEALPOWDER, FOR SUSPENSION4.68 %
INTRATRACHEALSUSPENSION0.76 %
INTRATUMORINJECTABLE NA
INTRATUMORINJECTION1.2 %
INTRATUMORPOWDER, FOR INJECTION SOLUTION NA
INTRATYMPANICSUSPENSION0.43 %W/W
INTRAVASCULARINJECTION8.6 mg/1mL
INTRAVASCULARINJECTION0.19 %
INTRAVASCULARSOLUTION NA
INTRAVENOUSINJECTABLE90 %
INTRAVENOUSINJECTABLE9 MG/1ML
INTRAVENOUSINJECTION18 MG/1ML
INTRAVENOUSINJECTION9.14 %
INTRAVENOUSINJECTION9 MG/ML
INTRAVENOUSINJECTION0.9 %W/V
INTRAVENOUSINJECTION, EMULSION6.2 MG/ML
INTRAVENOUSINJECTION, SOLUTION9 MG/1ML
INTRAVENOUSINJECTION, SOLUTION0.9 %
INTRAVENOUSLIQUID0.9 %
INTRAVENOUSLIQUID, WATER, STERILE, FOR INJECTION0.9 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION48.7 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED13.7 %
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED4.5 MG/1VIAL
INTRAVENOUSPOWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH 3.15 %
INTRAVENOUSSOLUTION0.9 %
INTRAVENOUSSOLUTION, INJECTION9 MG/ML
INTRAVENOUSSOLUTION, INJECTION8.9 %
INTRAVENOUSSOLUTION, INJECTION0.8 %
INTRAVENOUSSOLUTION, LIQUID801.1 uL/1mL
INTRAVENOUS BOLUSINJECTABLE0.9 %
INTRAVENOUS BOLUSSOLUTION, INJECTION0.9 %
INTRAVENOUS INFUSIONINJECTABLE9 MG/1ML
INTRAVENOUS INFUSIONINJECTION4.8 MG/1ML
INTRAVENOUS INFUSIONINJECTION, SOLUTION9 MG/1ML
INTRAVENOUS INFUSIONINJECTION, SOLUTION0.9 %
INTRAVESICALSOLUTION, INJECTION35.1 %
INTRAVITREALINJECTABLE10 %
INTRAVITREALINJECTION0.77 %
INTRAVITREALSUSPENSION, INJECTION0.55 %
IONTOPHORESISDRUG DELIVERY SYSTEM0.6 MG
IONTOPHORESISPATCH, CONTROLLED RELEASE3.1 MG
IONTOPHORESISSOLUTION0.6 %
IV - SCINJECTION8.6 MG/1ML
IV - SCINJECTION1.8 %
IV - SCLIQUID0.7 %
IV - SCPOWDER, FOR INJECTION SOLUTION0.68 %
IV - SCSOLUTION, INJECTION0.9 %
IV (INFUSION)SOLUTION9 MG/1ML
IV(INFUSION)INJECTABLE0.9 %
IV(INFUSION)INJECTION45 %
IV(INFUSION)INJECTION8.5 mg/1mL
IV(INFUSION)LIQUID0.9 %
IV(INFUSION)LIQUID, WATER, STERILE, FOR INJECTION0.8 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION45 %
IV(INFUSION)POWDER, FOR INJECTION SOLUTION, LYOPHILIZED, WITH 3.15 %
IV(INFUSION)SOLUTION, INJECTION9 MG/1ML
IV(INFUSION)SOLUTION, INJECTION0.9 %
IV(INFUSION)SUSPENSION, INJECTION0.9 %
NASALSOLUTION0.9 %
NASALSOLUTION, FOR INHALATION1.13 %
NASALSOLUTION, SPRAY0.68 %
NASALSOLUTION, SPRAY, METERED, PUMP0.093 %
NASALSPRAY7.5 MG/1ML
NASALSPRAY0.7 %
NASALSPRAY, METERED931.6 MCG/SPRAY
NASALSPRAY, METERED1.9 %
NERVE BLOCKINJECTABLE NA
NERVE BLOCKINJECTION7 MG/1ML
NERVE BLOCKINJECTION0.9 %
NERVE BLOCKSOLUTION, INJECTION0.9 %
OPHTHALMICDROPS0.65 %
OPHTHALMICGEL0.9 %
OPHTHALMICPOWDER, FOR SOLUTION0.9 %
OPHTHALMICPOWDER, FOR SUSPENSION NA
OPHTHALMICSOLUTION8 mg/1mL
OPHTHALMICSOLUTION4 %
OPHTHALMICSOLUTION0.05 %W/V
OPHTHALMICSOLUTION, DROPS45 MG/5ML
OPHTHALMICSOLUTION, DROPS8 mg/1mL
OPHTHALMICSOLUTION, DROPS0.9 %
OPHTHALMICSOLUTION/ DROPS8.3 MG/1ML
OPHTHALMICSOLUTION/DROPS0.82 %
OPHTHALMICSUSPENSION0.85 %
OPHTHALMICSUSPENSION, DROPS0.68 %
ORALCAPSULE6 MG
ORALCAPSULE, EXTENDED RELEASE20.72 MG
ORALDROPS NA
ORALGRANULE, FOR SUSPENSION13.5 MG
ORALPOWDER, FOR ORAL SOLUTION25.27 MG
ORALPOWDER, FOR ORAL SUSPENSION5 MG/5ML
ORALPOWDER, FOR SOLUTION NA
ORALPOWDER, FOR SUSPENSION12.5 MG/5ML
ORALSOLUTION0.9 %
ORALSOLUTION, ELIXIR2 MG/5ML
ORALSOLUTION, FOR INHALATION27 MG
ORALSOLUTION, SYRUP0.4 MG/1ML
ORALSUSPENSION20 MG/1ML
ORALSUSPENSION, FOR INHALATION17 MG/2ML
ORALSYRUP3 MG/1ML
ORALTABLET150 MG
ORALTABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE7.5 MG
ORALTABLET, CONTROLLED RELEASE36 MG
ORALTABLET, DELAYED ACTION24 MG
ORALTABLET, DELAYED RELEASE30 MG
ORALTABLET, EXTENDED RELEASE335.1 MG
ORALTABLET, FILM COATED100 MG
ORALTABLET, ORALLY DISINTEGRATING10 MG
ORALTABLET, SUSTAINED ACTION143.26 MG
ORALTABLET, SUSTAINED ACTION, COATED46.8 MG
OTICSUSPENSION0.53 %
PARENTERALINJECTABLE0.9 %
PARENTERALINJECTION24 %
PARENTERALLIQUID, WATER, STERILE, FOR INJECTION0.8 %
PERIDURALINJECTION0.81 %
PERINEURALINJECTION8.6 mg/1mL
PERINEURALINJECTION0.7 %
PHOTOPHERESISSOLUTION0.8 %
RECTALENEMA0.7 %
RECTALSOLUTION NA
RECTALSUPPOSITORY52.5 MG
RESPIRATORY (INHALATION)INHALANT0.86 %
RESPIRATORY (INHALATION)SOLUTION0.9 %W/V
RESPIRATORY (INHALATION)SOLUTION, AEROSOL, FOR INHALATION0.23 %
RESPIRATORY (INHALATION)SOLUTION, FOR INHALATION0.9 %W/V
RESPIRATORY (INHALATION)SUSPENSION, FOR INHALATION0.85 %W/V
RETROBULBARINJECTION0.86 %
SOFT TISSUEINJECTABLE0.66 %
SOFT TISSUEINJECTION0.85 %
SOFT TISSUEINJECTION, SUSTAINED ACTION0.9 %
SOFT TISSUESUSPENSION, INJECTION1.5 mg/1mL
SOFT TISSUESUSPENSION, INJECTION0.22 %
SUBARACHNOIDSOLUTION, INJECTION0.9 %
SUBCUTANEOUSIMPLANT77 MG
SUBCUTANEOUSINJECTABLE0.89 %
SUBCUTANEOUSINJECTION9 MG/1ML
SUBCUTANEOUSINJECTION6.08 MG/0.8ML
SUBCUTANEOUSINJECTION4.56 MG/0.6ML
SUBCUTANEOUSINJECTION4.2 MG/0.5ML
SUBCUTANEOUSINJECTION3.04 MG/0.4ML
SUBCUTANEOUSINJECTION0.44 %
SUBCUTANEOUSINJECTION, SOLUTION0.7 %
SUBCUTANEOUSLIQUID0.15 %
SUBCUTANEOUSSOLUTION9 mg/1mL
SUBCUTANEOUSSOLUTION0.7 %
SUBCUTANEOUSSOLUTION, INJECTION2.25 %
SUBCUTANEOUSSUSPENSION, INJECTION1.23 %
SUBMUCOSALINJECTION0.16 %
SUBMUCOSALSOLUTION, INJECTION16 %
TOPICALEMULSION, CREAM NA
TOPICALGEL0.18 %W/W
TOPICALJELLY NA
TOPICALLOTION0.3 %W/V
TOPICALOINTMENT NA
TOPICALOPHTHALMIC SUSPENSION DOSAGE FORM0.5 %W/V
TOPICALPATCH, CONTROLLED RELEASE3.1 MG
TOPICALSHAMPOO2.25 %W/W
TOPICALSOLUTION6.4 MG/ML
TOPICALSOLUTION0.9 %W/V
TOPICALSOLUTION, DROPS0.86 %W/V
TOPICALSOLUTION/DROPS0.82 %W/V
TOPICALSUSPENSION0.3 %W/W
TOPICALSUSPENSION, DROPS5.05 MG/ML
TRANSDERMALDRUG DELIVERY SYSTEM0.6 MG

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.